A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome-Reference-Cited by-同舟云学术

A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome

Published:2020-10-28 Issue:5 Volume:36 Page:1175-1182
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Dossier Claire,Prim Benjamin,Moreau Christelle,Kwon Thérésa,Maisin Anne,Nathanson Sylvie,De Gennes Christiane,Barsotti Katia,Bourrassi Abdelmajid,Hogan Julien,Deschênes Georges^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology, and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00467-020-04811-0.pdf

Reference39 articles.

1. Dossier C, Delbet JD, Boyer O, Daoud P, Mesples B, Pellegrino B, See H, Benoist G, Chace A, Larakeb A, Hogan J, Deschenes G (2019) Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study. Pediatr Nephrol 34:671–678

2. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grunfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550–557

3. Vivarelli M, Massella L, Ruggiero B, Emma F (2017) Minimal change disease. Clin J Am Soc Nephrol 12:332–345

4. Azib S, Macher MA, Kwon T, Dechartres A, Alberti C, Loirat C, Deschenes G, Baudouin V (2011) Cyclophosphamide in steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:927–932

5. Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384:1273–1281

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before Kidney Transplantation;Kidney International Reports;2024-08

2. Minimal Change Disease;Advances in Kidney Disease and Health;2024-07

3. Safety of Obinutuzumab in Children With Autoimmune Encephalitis and Early B-Cell Repopulation on Rituximab;Pediatric Neurology;2024-07

4. Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases;Kidney International Reports;2024-06

5. Application of CD38 monoclonal antibody in kidney disease;Frontiers in Immunology;2024-05-10